Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Healthia (ASX:HLA) share price on watch on $88 million physiotherapy acquisition

The Healthia Ltd (ASX: HLA) share price is on watch after announcing an $88.4 million physiotherapy acquisition.

Healthia buys Back in Motion (BIM)

Founded over 20 years ago, Back in Motion is one of the largest and fastest growing physiotherapy businesses in Australia and New Zealand, with a portfolio of 64 physiotherapy clinics supported by their associated physiotherapy clinics across ANZ.

Victoria is the location of 27 of these clinics, whilst New Zealand has another 13 clinics.

Historically, this business operated under a franchise model (though immediately transitioning to Healthia’s ownership after completing the the deal).

Healthia is buying this business for a total of $88.4 million, comprising $64.6 million of cash, $16.1 million of Clinic class shares, $5.8 million of new shares payable on completion and $1.9 million of cash payable on completion. In addition, a consideration (estimated at $4.2 million) may be payable between six months to 36 months after the acquisition if the business hits its future earnings targets.

Financial numbers

BIM made $62.9 million of ‘underlying’ revenue and $12.3 million of underlying EBITDA (EBITDA explained) in FY21.

Healthia expects this acquisition will add 12.7% to its underlying profit / earnings per share (EPS).

The ASX healthcare share said that Back in Motion has a track record of organic growth, with around 8% organic growth in FY21.

BIM also apparently has good customer growth and customer retention. As part of the acquisition, Healthia will also get purpose-built, industry specific systems and technology, which is branded Evo Suite – Healthia will get a 33% interest in the company that operates and develops Evo Suite.

Sonic Healthcare Ltd (ASX: SHL) is one of the other ASX healthcare shares that is growing through organic growth and acquisitions.

Capital raising

Approximately $53 million of the $60 million will be raised by Healthia through a fully underwritten placement and entitlement offer.

The fully underwritten institutional placement will raise approximately $22.3 million. There will also be a fully underwritten 1 for 4.3 pro rata accelerated non-renounceable entitlement to raise approximately $37.7 million.

The offer price of $1.80 represents a discount of 18.2% to the last closing price.

Thoughts on Healthia and the share price

Healthia seems like a pretty good business. It’s delivering organic revenue growth, profit margin increases and a steady stream of useful acquisitions. Like BIM. It seems like a good deal, though the capital raising is being done at a pretty deep discount to the last share price.

I’d be happy to take part in the capital raising, though I’m not sure about buying new shares on the market right now. A price under $2 could be compelling. I’ve also got my eyes on other ASX growth shares.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content